Are there gender differences in colorectal cancer test use prevalence and correlates?

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Amy McQueenWilliam Rakowski

Abstract

Despite evidence that screening tests reduce colorectal cancer incidence and mortality, screening prevalence is low. Gender differences in test uptake have been reported, but few studies examine correlates of test use by gender. Differences, if present, may inform strategies to increase test use. We examined gender differences in the prevalence and correlates of colorectal cancer test use [fecal occult blood test (FOBT) and endoscopy] using data from the 2002 to 2003 Health Information National Trends Survey. Male (n = 999) and female (n = 1687) respondents ages > or =50 years, without a personal history of colorectal cancer, were interviewed by telephone. Age-adjusted prevalence rates were reported for lifetime, recent, and repeat use by gender and test type. Multivariable logistic regression analyses were used to identify correlates of test use stratified by gender and colorectal cancer test type. More females reported only using FOBT in lifetime and in the past year, whereas more males reported repeat endoscopy use. The use of other tests or combinations of tests did not differ by gender. Consistent positive correlates of colorectal cancer test use for both genders included age, recent physician visits, recent breast or pros...Continue Reading

References

Mar 20, 1993·Lancet·W S AtkinD K Whynes
Dec 30, 1993·The New England Journal of Medicine·S J WinawerJ F Panish
Sep 28, 2000·Preventive Medicine·G A Brenes, E D Paskett
Nov 30, 2000·The New England Journal of Medicine·J S MandelL M Schuman
Jun 8, 2001·Preventive Medicine·E R WeitzmanK V Goins
Jul 18, 2001·American Journal of Preventive Medicine·J A ShapiroM R Nadel
Jul 18, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Feb 13, 2003·Archives of General Psychiatry·Ronald C KesslerAlan M Zaslavsky
May 15, 2003·Preventive Medicine·P BrawarskyL A Mucci
Sep 23, 2003·The American Journal of Gastroenterology·George N IoannouJason A Dominitz
Nov 26, 2003·Preventive Medicine·Nancy K JanzKenneth E Guire
Feb 26, 2004·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Vivek GoelYola Zdanowicz
Apr 7, 2004·Preventive Medicine·Sujha SubramanianTimothy L Hunt
Aug 19, 2004·Cancer·Helen I MeissnerPeter A Briss
Sep 8, 2004·Cancer Detection and Prevention·P BrawarskyP A Wood
Oct 30, 2004·Journal of Health Communication·David E NelsonSara Alden
Mar 1, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sujha SubramanianTimothy L Hunt
Sep 21, 2005·Preventive Medicine·Mary E CostanzaMilagros C Rosal
Feb 7, 2006·Cancer Detection and Prevention·Anthony GreisingerSally W Vernon

❮ Previous
Next ❯

Citations

Sep 28, 2010·Journal of Behavioral Medicine·Jack E BurkhalterJamie S Ostroff
Dec 15, 2007·Journal of Community Health·Paul C SchroyKaren M Emmons
Nov 24, 2011·Journal of Community Health·Michael YimTracy L Onega
Mar 7, 2013·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Kai Chow ChoiCarman W H Chan
Jun 16, 2009·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·David S WeinbergEric Bieber
Aug 9, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·LaVera M CrawleyMarilyn A Winkleby
Apr 12, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nisa M MaruthurJeanne M Clark
Jun 28, 2012·BMC Gastroenterology·Stefan GrothThomas Rösch
May 28, 2013·BMC Public Health·Paul RitvoLinda Rabeneck
Sep 17, 2010·Annals of Family Medicine·Joshua J FentonLaura-Mae Baldwin
Feb 25, 2014·Cancer Causes & Control : CCC·Eric A MillerKenneth C Schoendorf
Mar 18, 2011·Women's Health·Sandeep Krishnan, Jacqueline L Wolf
Feb 28, 2007·Journal of Women's Health·Neeraja B PetersonRobert S Dittus
Dec 14, 2011·Journal of Women's Health·Peter N AbotchieXianglin L Du
May 1, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kathryn A MartinezJean G Ford
Dec 19, 2014·Health Economics·Mary K Hamman, Kandice A Kapinos
Mar 5, 2008·The Breast Journal·Natalie CoburnBlake Cady
Dec 3, 2014·Health & Place·Sandi L PruittSamir Gupta
Jan 25, 2012·Gastroenterology Research and Practice·Gilda G MedinaSally W Vernon
Apr 4, 2018·Climacteric : the Journal of the International Menopause Society·I Olver
Aug 12, 2010·The American Journal of Gastroenterology·Hermann BrennerSabrina Hundt
Sep 2, 2008·The American Journal of Gastroenterology·Steven ItzkowitzBarry M Berger
Jun 27, 2008·Medical Care·Patricia Carcaise-Edinboro, Cathy J Bradley
May 2, 2019·Journal of Medical Screening·Charlotte VrintenChristian von Wagner
Apr 1, 2009·Diseases of the Colon and Rectum·Mansoureh AkouchekianMehdi Shafa
Aug 25, 2020·Cancer Medicine·Monika SieverdingChristian von Wagner
May 28, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Caitlin C MurphyAmit G Singal
Nov 20, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Caitlin C MurphyAmit G Singal
Apr 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Vanessa de BossetMichael Pignone
Jan 24, 2021·Journal of Translational Medicine·Carly A ConranJianfeng Xu
Oct 24, 2021·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kyle StallerJonas F Ludvigsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Helen I MeissnerSally W Vernon
Journal of General Internal Medicine
Allison B Rosen, Eric C Schneider
© 2022 Meta ULC. All rights reserved